Electrochemical sensor using cobalt oxide-modified porous carbon for uric acid determination

Early Detection and Monitoring of Nephrolithiasis: The Potential of Electrochemical Sensors

Nephrolithiasis (kidney stone disease) continues to pose a significant global health challenge, affecting millions of individuals and placing substantial economic pressures on healthcare systems. Traditional diagnostic methods-such as computed tomography (CT), ultrasound, and basic urinalysis-are often limited by issues including radiation exposure, lower sensitivity in detecting small stones, operator dependency, and the inability to provide real-time analysis. In response, electrochemical sensors have emerged as innovative and powerful tools capable of the rapid, sensitive, and specific detection of key biomarkers associated with nephrolithiasis. This review highlights the advances in electrochemical approaches for monitoring oxalate and uric acid, the two primary metabolites implicated in kidney stone formation. We discuss the principles of electrode design and fabrication, including nanomaterial integration, 3D printing, and molecular imprinting, which have markedly improved detection limits and selectivity. Furthermore, we critically evaluate the practical challenges-such as sensor fouling, reproducibility, and stability in complex biological matrices-that currently impede widespread clinical implementation. The potentials for miniaturization and point-of-care integration are emphasized, with an eye toward continuous or home-based monitoring systems that can offer personalized insights into risk of stone formation and progression. By consolidating recent findings and exploring future trends in multi-analyte detection and wearable diagnostics, this review provides a roadmap for translating electrochemical sensors from research laboratories to routine clinical practice, ultimately aiming to enhance early intervention and improve patient outcomes in nephrolithiasis.

Molecularly imprinted nanocomposites-based synthetic antibodies for uric acid-specific non-invasive electrochemical gout sensors

A disposable electrochemical sensor is introduced for the selective recognition of uric acid (UA), a crucial biomarker for gout arthritis. The sensor employs synthetic antibodies composed of molecularly imprinted polythiophene (MIP) laden graphitic carbon nitride (GCN) nanocomposites for the selective recognition of UA. Microscopic analysis demonstrates an increase in surface roughness and kurtosis after removing the template, indicating the fabrication and functionalization of the MIP/GCN sensors. These sensors exhibit excellent electrochemical properties, characterized by electrochemical impedance spectroscopy (EIS) and voltammetric (CV, DPV) methods. The sensor displays a wide linear detection range (1-500 µM), encompassing the normal UA levels in human saliva, high sensitivity (5.47 µA/cm2.µM), a low limit of detection (0.21 µM), and limit of quantification (0.64 µM). The sensor also exhibits low cross-sensitivity to common salivary interferences, including urea, creatinine, ascorbic acid, glucose, and glutamine. The MIP/GCN sensor accurately identifies UA in human saliva, resulting in a recovery of 93.25 ± 0.33%. Electrochemical studies, utilizing [Fe(CN)6]4-/3- as a redox probe, also provide insights into the mechanisms of interfacial redox reactions and selective UA recognition. This work demonstrates a significant improvement in POC testing, providing a reliable and non-invasive tool for gout diagnosis.

ZnS and Reduced Graphene Oxide Nanocomposite-Based Non-Enzymatic Biosensor for the Photoelectrochemical Detection of Uric Acid

In this work, we report a study of a zinc sulfide (ZnS) nanocrystal and reduced graphene oxide (RGO) nanocomposite-based non-enzymatic uric acid biosensor. ZnS nanocrystals with different morphologies were synthesized through a hydrothermal method, and both pure nanocrystals and related ZnS/RGO were characterized with SEM, XRD and an absorption spectrum and resistance test. It was found that compared to ZnS nanoparticles, the ZnS nanoflakes had stronger UV light absorption ability at the wavelength of 280 nm of UV light. The RGO significantly enhanced the electron transfer efficiency of the ZnS nanoflakes, which further led to a better photoelectrochemical property of the ZnS/RGO nanocomposites. The ZnS nanoflake/RGO nanocomposite-based biosensor showed an excellent uric acid detecting sensitivity of 534.5 μA·cm-2·mM-1 in the linear range of 0.01 to 2 mM and a detection limit of 0.048 μM. These results will help to improve non-enzymatic biosensor properties for the rapid and accurate clinical detection of uric acid.

Europium Metal-Organic Framework with a Tetraphenylethylene-Based Ligand: A Dual-Mechanism Quenching Immunosensor for Enhanced Electrochemiluminescence via the Coordination Trigger

The effective applications of electrochemiluminescence (ECL) across various fields necessitate ongoing research into novel luminophores and ECL strategies. In this study, self-luminous flower-like nanocomposites (Eu-tcbpe-MOF) were prepared by coordination self-assembly using the aggregation-induced emission material 1,1,2,2-tetrakis(4-carboxyphenyl)ethylene (H4TCBPE) and Eu(III) ions as the precursors. Compared with the monomers and aggregates of H4TCBPE, Eu-tcbpe-MOF exhibits stronger ECL emission. Such enhanced electrochemiluminescence is due to coordination as the coordination-triggered electrochemiluminescence (CT-ECL) enhancement effect. In this study, a cubic-structured nanocomposite (Co9S8@Au@MoS2) was used as an efficient quencher, and a more sensitive ECL detection platform was achieved by two quenching mechanisms: resonance energy transfer and competitive consumption of coreactants. N,N-Diethylethanolamine (DBAE) was used as a coreactant, and DBAE has a faster electron transfer rate and stronger energy supply efficiency than the traditional anodoluminescent coreactant tripropylamine, which effectively improves the ECL signal intensity of Eu-tcbpe-MOF. Hence, a sandwich-type ECL immunosensor was prepared by employing a dual-quenching mechanism, utilizing Eu-tcbpe-MOF as the detection probe and Co9S8@Au@MoS2 as the quencher, achieving precise detection of carcinoembryonic antigen from 0.1 pg·mL-1 to 100 ng·mL-1 with a detection limit of 35.1 fg·mL-1.

Enzyme-free electrochemical sensor platforms based on transition metal nanostructures for clinical diagnostics

The detection of emergent biomarkers is of key significance in numerous clinical, biological, and biomedical fields. Specifically, the design and development of potent electrochemical lactic acid and glucose sensing platforms are especially in great demand in a variety of industries, including those involved in clinical analysis, biomedicine, biological, food, cosmetics, pharmaceuticals, leather, sports, and chemical industries. Nanostructured transition metal-derived materials have opened the door to electrochemical sensors and biosensors due to their advantages of high surface-to-volume ratio, surface reaction activity, catalytic activity, and strong adsorption capability. The primary aim of the present minireview is to highlight the advancement of enzyme-free electrochemical sensor platforms based on transition metal-derived nanostructures with high electrocatalytic activity and sensing performance towards lactic acid and glucose in practical samples. The preparation approaches, structural and composition monitoring, fabrication of sensing electrodes, catalytic activity, sensing performance in real samples, and the exploration of sensing mechanisms are majorly concentrated on in most of our recent research studies. Moreover, state-of-the-art transition metal-derived nanostructure-derived electrochemical sensor platforms, critical comparison of the analytical performance of the sensor platforms, and the future perspectives of the enzyme-free electrochemical sensor for clinical diagnostics are described.